Affimed(AFMD)

产业链观察05-29 20:16

#药闻简讯# $Affimed(AFMD)$ AFM24联合阿替利珠单抗联合治疗EGFR野生型非小细胞肺癌获得快速通道认定查看全文

产业链观察05-24 18:05

#药闻简讯# $Affimed(AFMD)$ AFM 24联合atezolizumab治疗EGFR野生型（EGFR-WT）非小细胞肺癌（NSCLC）患者的II期研究的初步结果。#ASCO2024#
背景： 免疫疗法组合可能是克服对现有疗法的耐药性的有希望的策略。AFM24是一类第一个双特异性四价先天性细胞增殖剂，结合先天性效应细胞（NK细胞和...查看全文

财报披露「修正」

Affimed(AFMD)06-07 05:15

$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194  Act: 34  Size: 77 KB 网页链接查看全文

财报披露

Affimed(AFMD)05-28 18:55

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572  Act: 34  Size: 179 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-12 20:05

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605  Act: 34  Size: 429 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-27 04:55

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160  Act: 34  Size: 38 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-03 18:15

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290  Act: 34  Size: 41 KB 网页链接查看全文

财报披露

Affimed(AFMD)05-24 05:25

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116  Act: 34  Size: 37 KB 网页链接查看全文

Pharmachoi2020-04-16 20:41

$Affimed(AFMD)$ first Patient Successfully Dosed in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers查看全文

Pharmachoi2020-04-05 11:33

$Affimed(AFMD)$ 2020年4月2日–致力于让患者恢复其与生俱来的抗癌能力的临床阶段免疫肿瘤公司（纳斯达克:AFMD)今天提供了其应对COVID-19冠状病毒大流行持续蔓延的最新运营情况。阿菲迈德还宣布，将于2020年4月28日(星期二)美国东部时间上午8:30召开电话会议，讨论其2019年全年的财务业绩和最近的...查看全文

Pharmachoi2020-04-03 23:12

$Affimed(AFMD)$ $afmd expect preliminary AFM13 data in PTCL at 2020 year-end, with more visibility on an accelerated regulatory path. Initial AFM24 data in EGFR+ solid tumors is expected in late 2020 and could provide additional upside.查看全文

Pharmachoi2020-04-02 19:15

$Affimed(AFMD)$ SUMMARY:
- AFM13 FDA granted Orphan Drug Designation and activated 39 clinical studies sites
- AFM24 Phase 1/2a started
- Genentech collaboration progressing and unimpacted by the COVID-19查看全文

Pharmachoi2020-04-02 09:31

$Affimed(AFMD)$ Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma
Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma查看全文

Replix锐璞美股2020-01-13 19:36

$Affimed(AFMD)$ 2018年肿瘤治疗的翘楚Genentech和迷你药企--AFMD达成了高达50亿美元的合作开发协议，新鲜劲一过这家公司股票就开始下跌。被Genentech相中是否有可能璞玉变明珠呢？请查看我们的分析：网页链接。
$阿玛琳(AMRN)$ $百济神州(BGNE)$
@淘沙...查看全文

飞冲天2020-01-09 22:26

$Affimed(AFMD)$ Wellington一出手就是580万股，查看全文

晶莹蓝宝石2019-07-31 23:36

$Affimed(AFMD)$ 好像有故事啊查看全文

王王可可2019-05-23 12:41

$Affimed(AFMD)$ 跌到2.6就买查看全文

晶莹蓝宝石2019-05-02 01:56

$Affimed(AFMD)$ 要开始抛物线上行了查看全文

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160  Act: 34  Size: 38 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605  Act: 34  Size: 429 KB 网页链接

财报披露「修正」

$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194  Act: 34  Size: 77 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290  Act: 34  Size: 41 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572  Act: 34  Size: 179 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116  Act: 34  Size: 37 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-080581  Act: 34  Size: 168 KB 网页链接

年度财报

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-24-040310  Act: 34  Size: 12 MB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-064790  Act: 34  Size: 11 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-059965  Act: 34  Size: 29 KB 网页链接